Literature DB >> 9327745

Role of glycosaminoglycans in determining the helicity of paired helical filaments.

M Arrasate1, M Pérez, J M Valpuesta, J Avila.   

Abstract

It is known from previous work that tau is the main component of paired helical filaments (PHFs) and that it can assemble in vitro into polymers resembling PHFs when high concentrations of protein are used. In the search for molecules that can facilitate tau polymerization, a component of neurofibrillary tangles, heparan sulfate (or its more sulfated form, heparin), and other glycosaminoglycans have been tested. Glycosaminoglycans, in the sulfated but not in the unsulfated form, facilitate not only tau assembly but also the formation of polymers resembling PHFs. Conversely, PHFs were found to contain heparan sulfate and chondroitin sulfate. Heparinase or chondroitinase treatment of PHFs results in the formation of straight structures. All of these results suggest a role for sulfated glycosaminoglycans in determining the helicity of PHFs.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9327745      PMCID: PMC1858049     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  43 in total

1.  Filament heterogeneity within the dystrophic neurites of senile plaques suggests blockage of fast axonal transport in Alzheimer's disease.

Authors:  D Praprotnik; M A Smith; P L Richey; H V Vinters; G Perry
Journal:  Acta Neuropathol       Date:  1996       Impact factor: 17.088

2.  Polymerization of tau into filaments in the presence of heparin: the minimal sequence required for tau-tau interaction.

Authors:  M Pérez; J M Valpuesta; M Medina; E Montejo de Garcini; J Avila
Journal:  J Neurochem       Date:  1996-09       Impact factor: 5.372

Review 3.  The role of heparan sulfate proteoglycans in the pathogenesis of Alzheimer's disease.

Authors:  D H Small; T Williamson; G Reed; H Clarris; K Beyreuther; C L Masters; V Nurcombe
Journal:  Ann N Y Acad Sci       Date:  1996-01-17       Impact factor: 5.691

4.  The macromolecular structure of type-VI collagen. Formation and stability of filaments.

Authors:  H J Kuo; D R Keene; R W Glanville
Journal:  Eur J Biochem       Date:  1995-09-01

5.  Alzheimer's disease hyperphosphorylated tau sequesters normal tau into tangles of filaments and disassembles microtubules.

Authors:  A C Alonso; I Grundke-Iqbal; K Iqbal
Journal:  Nat Med       Date:  1996-07       Impact factor: 53.440

6.  Glycosylation of microtubule-associated protein tau: an abnormal posttranslational modification in Alzheimer's disease.

Authors:  J Z Wang; I Grundke-Iqbal; K Iqbal
Journal:  Nat Med       Date:  1996-08       Impact factor: 53.440

7.  The intracellular fate of apolipoprotein E is tau dependent and apoe allele-specific.

Authors:  S Lovestone; B H Anderton; C Hartley; T G Jensen; A L Jorgensen
Journal:  Neuroreport       Date:  1996-04-10       Impact factor: 1.837

8.  Stable expression and secretion of apolipoproteins E3 and E4 in mouse neuroblastoma cells produces differential effects on neurite outgrowth.

Authors:  S Bellosta; B P Nathan; M Orth; L M Dong; R W Mahley; R E Pitas
Journal:  J Biol Chem       Date:  1995-11-10       Impact factor: 5.157

9.  Assembly of microtubule-associated protein tau into Alzheimer-like filaments induced by sulphated glycosaminoglycans.

Authors:  M Goedert; R Jakes; M G Spillantini; M Hasegawa; M J Smith; R A Crowther
Journal:  Nature       Date:  1996-10-10       Impact factor: 49.962

10.  Alzheimer-associated presenilins 1 and 2: neuronal expression in brain and localization to intracellular membranes in mammalian cells.

Authors:  D M Kovacs; H J Fausett; K J Page; T W Kim; R D Moir; D E Merriam; R D Hollister; O G Hallmark; R Mancini; K M Felsenstein; B T Hyman; R E Tanzi; W Wasco
Journal:  Nat Med       Date:  1996-02       Impact factor: 53.440

View more
  16 in total

Review 1.  Filamentous nerve cell inclusions in neurodegenerative diseases: tauopathies and alpha-synucleinopathies.

Authors:  M Goedert
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1999-06-29       Impact factor: 6.237

Review 2.  Disorder-to-order conformational transitions in protein structure and its relationship to disease.

Authors:  Paola Mendoza-Espinosa; Victor García-González; Abel Moreno; Rolando Castillo; Jaime Mas-Oliva
Journal:  Mol Cell Biochem       Date:  2009-04-09       Impact factor: 3.396

Review 3.  The tauopathies: toward an experimental animal model.

Authors:  M Goedert; M Hasegawa
Journal:  Am J Pathol       Date:  1999-01       Impact factor: 4.307

4.  Fibers of tau fragments, but not full length tau, exhibit a cross beta-structure: implications for the formation of paired helical filaments.

Authors:  A M Giannetti; G Lindwall; M F Chau; M J Radeke; S C Feinstein; L A Kohlstaedt
Journal:  Protein Sci       Date:  2000-12       Impact factor: 6.725

5.  Ferritin is associated with the aberrant tau filaments present in progressive supranuclear palsy.

Authors:  M Pérez; J M Valpuesta; E M de Garcini; C Quintana; M Arrasate; J L López Carrascosa; A Rábano; J García de Yébenes; J Avila
Journal:  Am J Pathol       Date:  1998-06       Impact factor: 4.307

6.  The tau code.

Authors:  Jesús Avila
Journal:  Front Aging Neurosci       Date:  2009-07-30       Impact factor: 5.750

Review 7.  Tau function and dysfunction in neurons: its role in neurodegenerative disorders.

Authors:  Jesús Avila; Filip Lim; Francisco Moreno; Carlos Belmonte; A Claudio Cuello
Journal:  Mol Neurobiol       Date:  2002-06       Impact factor: 5.590

Review 8.  Tau-based treatment strategies in neurodegenerative diseases.

Authors:  Anja Schneider; Eckhard Mandelkow
Journal:  Neurotherapeutics       Date:  2008-07       Impact factor: 7.620

9.  Defects in the medial entorhinal cortex and dentate gyrus in the mouse model of Sanfilippo syndrome type B.

Authors:  Kazuhiro Ohmi; Hui-Zhi Zhao; Elizabeth F Neufeld
Journal:  PLoS One       Date:  2011-11-09       Impact factor: 3.240

10.  Are tau aggregates toxic or protective in tauopathies?

Authors:  Catherine M Cowan; Amrit Mudher
Journal:  Front Neurol       Date:  2013-08-13       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.